Immunogenicity and Safety Among Adults of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation (Intramuscular Route).
Phase of Trial: Phase IV
Latest Information Update: 26 May 2016
At a glance
- Drugs Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sanofi
- 24 Feb 2010 Primary endpoints added as reported by ClinicalTrials.gov.
- 04 Mar 2009 New trial record